Back to Urology
Urologyv1992Evidence-Based

International Prostate Symptom Score (IPSS)/American Urological Association Symptom Index (AUA-SI)

Measures severity of benign prostatic hyperplasia (BPH) symptoms using 7 questions about urinary symptoms to guide treatment decisions.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
ipss score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The International Prostate Symptom Score (IPSS)/American Urological Association Symptom Index (AUA-SI) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within urology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

IPSS Score = Sum of 7 symptom questions: Incomplete emptying (0-5) + Frequency (0-5) + Intermittency (0-5) + Urgency (0-5) + Weak stream (0-5) + Straining (0-5) + Nocturia (0-5). Total range: 0-35 points.

Clinical Pearls & Practice Notes

  • The IPSS and AUA-SI are identical questionnaires with the same 7 questions and scoring system.
  • Each question is scored from 0 (not at all) to 5 (almost always), except nocturia which is scored by number of times per night.
  • An optional 8th question about quality of life can be included but is not part of the total score.
  • The score helps guide treatment decisions: mild (0-7) - watchful waiting, moderate (8-19) - medical therapy, severe (20-35) - consider surgery.
  • The questionnaire should be completed by the patient and can be used to monitor treatment response over time.
  • Validated for use in men with lower urinary tract symptoms suggestive of BPH.
  • Does not diagnose BPH but quantifies symptom severity and impact on quality of life.

Evidence & Literature Citations

  1. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992 Nov;148(5):1549-57. doi: 10.1016/s0022-5347(17)36966-5.
  2. Cockett AT, Aso Y, Denis L, Khoury S, Barry M, Carlton CE Jr, et al. World Health Organization Consensus Committee recommendations concerning the diagnosis of BPH. Prog Urol. 1991 Nov;1(6):957-72.
  3. Bosch JL, Hop WC, Kirkels WJ, Schröder FH. The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br J Urol. 1995 Dec;76(6):625-33.

Score Interpretation Ranges

Mild0 – 7 pts

Mild BPH symptoms

Moderate8 – 19 pts

Moderate BPH symptoms

Severe20 – 35 pts

Severe BPH symptoms

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.